Quick Answer
Kura Oncology, Inc. reported Stockholders Equity of $174.14 million for the year ending 2025.
- Kura Oncology, Inc. showed a decrease of -57.9% in Stockholders Equity from 2024 to 2025.
- This data is from Kura Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: -$108.1 thousand | Q3 2013: -$114.2 thousand | Q1 2014: -$129.7 thousand | Q2 2014: -$136.6 thousand | Q3 2014: -$143.0 thousand | Q1 2015: $48.89 million | Q2 2015: $43.32 million | Q3 2015: $37.78 million | Q1 2016: $76.07 million | Q2 2016: $70.04 million | Q3 2016: $63.67 million | Q1 2017: $50.24 million | Q2 2017: $43.64 million | Q3 2017: $89.20 million | Q1 2018: $124.80 million | Q2 2018: $112.40 million | Q3 2018: $174.61 million | Q1 2019: $149.57 million | Q2 2019: $246.58 million | Q3 2019: $233.58 million | Q1 2020: $203.20 million | Q2 2020: $322.37 million | Q3 2020: $306.50 million | Q1 2021: $585.99 million | Q2 2021: $558.55 million | Q3 2021: $533.76 million | Q1 2022: $476.25 million | Q2 2022: $449.49 million | Q3 2022: $419.62 million | Q1 2023: $395.18 million | Q2 2023: $459.68 million | Q3 2023: $429.94 million | Q1 2024: $505.08 million | Q2 2024: $466.07 million | Q3 2024: $423.77 million | Q1 2025: $364.41 million | Q2 2025: $305.49 million | Q3 2025: $242.54 million.
- Over the full 16 years of available data (2011 to 2025), Kura Oncology, Inc.'s Stockholders Equity has grown by 256,064.2%.
- Historical annual values: Fiscal year 2025: $174.14 million | Fiscal year 2024: $413.64 million | Fiscal year 2023: $397.27 million | Fiscal year 2022: $420.28 million | Fiscal year 2021: $506.61 million | Fiscal year 2020: $610.91 million | Fiscal year 2019: $218.78 million | Fiscal year 2018: $160.99 million | Fiscal year 2017: $79.87 million | Fiscal year 2016: $56.88 million | Fiscal year 2015: $82.10 million | Fiscal year 2014: -$3.43 million | Fiscal year 2014: $0.00 | Fiscal year 2013: -$124.0 thousand | Fiscal year 2012: -$95.3 thousand | Fiscal year 2011: -$68.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: